Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07543146Completed
Randomised trial of serrapeptase in trismus (2 arms), sponsored by Sharif Medical Research Center. Primary endpoint: Postoperative Facial Swelling at Day 7. Started Jun 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07543146.